Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Epinephrine Hydrochloride Responsiveness

Epinephrine Hydrochloride Responsiveness This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor.—We read with great interest two adjacent articles in the December 1976 issue of the Archives by Becker and Shin (94:2057-2058) and by Shin and co-workers (94:2059-2060). These articles suggest that epinephrine hydrochloride responsiveness correlates with the occurrence of field loss in people with elevated intraocular pressure levels. This observation is important in trying to understand the pathogenic mechanism and the clinical manifestations in glaucoma. However, we would like to urge caution in using "epinephrine responsiveness" as an indication for therapy in individuals with abnormal pressure, at least until further evidence is available. In a report by Becker and Morton (Am J Ophthalmol 62:272-277, 1966), 50 subjects were treated with epinephrine to one eye and followedup prospectively for four to five years. Of the seven individuals in whom visual field loss developed, only two were "epinephrine responders" by the criterion used in the recent article by Becker http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Ophthalmology American Medical Association

Epinephrine Hydrochloride Responsiveness

Loading next page...
 
/lp/american-medical-association/epinephrine-hydrochloride-responsiveness-Tcgf8AVhXs

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1977 American Medical Association. All Rights Reserved.
ISSN
0003-9950
eISSN
1538-3687
DOI
10.1001/archopht.1977.04450050172023
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor.—We read with great interest two adjacent articles in the December 1976 issue of the Archives by Becker and Shin (94:2057-2058) and by Shin and co-workers (94:2059-2060). These articles suggest that epinephrine hydrochloride responsiveness correlates with the occurrence of field loss in people with elevated intraocular pressure levels. This observation is important in trying to understand the pathogenic mechanism and the clinical manifestations in glaucoma. However, we would like to urge caution in using "epinephrine responsiveness" as an indication for therapy in individuals with abnormal pressure, at least until further evidence is available. In a report by Becker and Morton (Am J Ophthalmol 62:272-277, 1966), 50 subjects were treated with epinephrine to one eye and followedup prospectively for four to five years. Of the seven individuals in whom visual field loss developed, only two were "epinephrine responders" by the criterion used in the recent article by Becker

Journal

Archives of OphthalmologyAmerican Medical Association

Published: May 1, 1977

There are no references for this article.